{"id":5921,"date":"2013-04-05T13:41:47","date_gmt":"2013-04-05T17:41:47","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=5921"},"modified":"2013-04-05T13:42:01","modified_gmt":"2013-04-05T17:42:01","slug":"idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921","title":{"rendered":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; Idenix Pharmaceuticals Inc(NASDAQ:IDIX)\u00a0on May 30, 2002 is a bio-pharmaceutical company, chiefly engaged in the discovery and development of drugs for the treatment of human viral diseases. At present the Company&#8217;s primary research and development is focused on the treatment of patients with hepatitis C virus (HCV). In June 2012, the Company completed a three-day proof-of-concept study designed to evaluate 64 treatment-naive HCV genotype 1, 2, 3 or 4-infected patients. Of late the FDA granted Fast Track designation for IDX719. On January 25, 2013, the Company has entered into a non-exclusive collaboration agreement with other pharmaceutical firms for the clinical evaluation of all oral DAA HCV combination therapies.<\/p>\n<p style=\"text-align: justify;\">Idenix Pharmaceuticals Inc (NASDAQ:IDIX) is currently trading at $3.51, down by 4.36% With a total trading volume of around $491M, the shares of the company are regularly traded on the NASDAQ.\u00a0 A study of the last year\u2019s quoted stocks reveals that the price ranged between $ 3.21 to as high as $ 11.30, with an average daily trading of\u00a0 1.77 million shares.<\/p>\n<p style=\"text-align: justify;\">Despite the presence of several pharmaceutical giants on NASDAQ, the prospect of Idenix Pharmaceuticals is bright. Of late, trading analysis reports clearly indicate that investors have shown a great dependence on the company, despite the gross negative trend in the money market in the holistic view of the present macro economic situation. This has obviously been due to the aggressive expansion strategy of the Idenix Pharmaceuticals in recent times. Its latest research in the field of treatment of highly incurable diseases like HIV, Hepatitis B, and related viral diseases has tremendous marketing potential.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; Idenix Pharmaceuticals Inc(NASDAQ:IDIX)\u00a0on May 30, 2002 is a bio-pharmaceutical company, chiefly engaged in the discovery and development of drugs for [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":5922,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[1945,1946],"stock_ticker":[],"class_list":["post-5921","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-idenix-pharmaceuticals-inc-nasdaqidix","tag-nasdaqidix","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; Idenix Pharmaceuticals Inc(NASDAQ:IDIX)\u00a0on May 30, 2002 is a bio-pharmaceutical company, chiefly engaged in the discovery and development of drugs for [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-04-05T17:41:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2013-04-05T17:42:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs\",\"datePublished\":\"2013-04-05T17:41:47+00:00\",\"dateModified\":\"2013-04-05T17:42:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\"},\"wordCount\":263,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg\",\"keywords\":[\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX)\",\"NASDAQ:IDIX\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\",\"name\":\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg\",\"datePublished\":\"2013-04-05T17:41:47+00:00\",\"dateModified\":\"2013-04-05T17:42:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921","og_locale":"en_US","og_type":"article","og_title":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR","og_description":"Boston, MA 04\/05\/2013 (wallstreetpr) &#8211; Idenix Pharmaceuticals Inc(NASDAQ:IDIX)\u00a0on May 30, 2002 is a bio-pharmaceutical company, chiefly engaged in the discovery and development of drugs for [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-04-05T17:41:47+00:00","article_modified_time":"2013-04-05T17:42:01+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs","datePublished":"2013-04-05T17:41:47+00:00","dateModified":"2013-04-05T17:42:01+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921"},"wordCount":263,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg","keywords":["Idenix Pharmaceuticals Inc (NASDAQ:IDIX)","NASDAQ:IDIX"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921","url":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921","name":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg","datePublished":"2013-04-05T17:41:47+00:00","dateModified":"2013-04-05T17:42:01+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/04\/pharma-1.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/idenix-pharmaceuticals-inc-nasdaqidix-develops-new-drugs-5921#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Idenix Pharmaceuticals Inc (NASDAQ:IDIX) develops new drugs"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/5921","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=5921"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/5921\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/5922"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=5921"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=5921"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=5921"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=5921"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}